Unlocking Success: Thermo Fisher Stock Prediction 2025 2030 2040 2050 – A Positive Outlook!

You are currently viewing Unlocking Success: Thermo Fisher Stock Prediction 2025 2030 2040 2050 – A Positive Outlook!

Thermo Fisher Stock Prediction 2025 – Thermo Fisher Scientific Inc. (TMO) is a global provider of life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services.

If you are considering investing in Thermo Fisher stock for the long term, it is important to analyze its potential growth and performance. Our Thermo Fisher (TMO) Stock Forecast is based on a deep technical analysis and past performance of Thermo Fisher Stock to help you make an informed decision.

To begin with, it is essential to understand Thermo Fisher’s business model and financial data. Once you have a clear understanding of the company’s operations and financial strength, you can determine whether Thermo Fisher (TMO) stock is a good buy or not.

Our Thermo Fisher (TMO) Stock Price Forecast covers the stock’s potential growth and performance for the years 2024, 2025, 2030, and 2040 to help you make an informed investment decision.

Contents

About Thermo Fisher Scientific Inc.

Thermo Fisher Scientific founded in 1956 and headquartered in Waltham, Massachusetts, Company is a leading provider of scientific solutions to help customers solve complex analytical challenges, improve patient diagnostics, and increase laboratory productivity.

Thermo Fisher Scientific Inc. is a global provider of life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services.

  1. Life Sciences Solutions segment – The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, drug and vaccine discovery, and production, as well as infection and disease diagnosis.
  2. Analytical Instruments segment – Its Analytical Instruments segment provides instruments, consumables, software, and services for research, industrial, and clinical laboratories, among others.
  3. Specialty Diagnostics segment – Thermo Fisher’s Specialty Diagnostics segment offers a range of immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments, as well as blood test systems for allergy, asthma, and autoimmune diseases. The segment also provides culture media, collection and transport systems, human leukocyte antigen typing and testing, and healthcare products.

The company markets its products and services under several brands, including –

  • Thermo Scientific,
  • Applied Biosystems,
  • Invitrogen,
  • Fisher Scientific,
  • Unity Lab Services, and
  • Patheon and PPD.

Customers of Thermo Fisher – Its customers include pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.

Founded in 1956 and headquartered in Waltham, Massachusetts, Thermo Fisher Scientific is a leading provider of scientific solutions to help customers solve complex analytical challenges, improve patient diagnostics, and increase laboratory productivity.

Read More – Investor’s Wellness Check: SYRA Health Stock Price Prediction 2025 2030 2040 2050 2060 – Positive Surges Ahead!

Financial Overview of Thermo Fisher Scientific (TMO)

Company ParametersValues
Stock NameThermo Fisher Scientific Inc
Stock ExchangeNYSE
Stock/Ticker SymbolTMO
Sector/IndustryHealthcare
Market Cap218.71B
Revenue (ttm)42.86B
Net Income (ttm)6.00B
Shares Out381.31M
EPS (ttm)15.45
PE Ratio37.08
Forward PE26.33
Dividend$1.56 (0.27%)
Ex-Dividend DateMar 14, 2024
Volume1,402,207
Open574.01
Previous Close573.56
Day’s Range567.84 – 575.16
52-Week Range415.60 – 603.82
Beta0.80
AnalystsBuy
Price Target594.17 (+3.74%)
Earnings DateApr 24, 2024
Official WebsiteThermo Fisher

Thermo Fisher Stock Price Chart

Thermo Fisher Stock Price Chart
@Courtesy Yahoo Finance

Thermo Fisher Revenue Details

Thermo Fisher Revenue

Thermo Fisher Revenue Chart

Thermo Fisher Revenue Chart

Thermo Fisher Stock Price Prediction 2025 (2024-2060)

Here are the year wise prediction –

YearMin PriceMax Price
2024$517.00$685.75
2025$657.20$904.77
2026$893.50$1,097.05
2027$1,077.37$1,224.49
2028$1,098.11$1,255.25
2029$816.56$1,263.30
2030$918.73$1,140.99
2035$1,120.67$1,969.39
2040$1,424.78$2,687.83
2045$2,957.49$3,241.47
2050$3,332.63$3,687.09

Thermo Fisher Stock Price Prediction 2024 | Thermo Fisher Stock Forecast 2024

YearMin PriceMax Price
2024$517.00$685.75

Thermo Fisher Stock Price Prediction 2025 | Thermo Fisher Stock Forecast 2025

YearMin PriceMax Price
2025$657.20$904.77

Thermo Fisher Stock Price Prediction 2026 | Thermo Fisher Stock Forecast 2026

YearMin PriceMax Price
2026$893.50$1,097.05

Thermo Fisher Stock Price Prediction 2027 | Thermo Fisher Stock Forecast 2027

YearMin PriceMax Price
2027$1,077.37$1,224.49

Thermo Fisher Stock Price Prediction 2028 | Thermo Fisher Stock Forecast 2028

YearMin PriceMax Price
2028$1,098.11$1,255.25

Thermo Fisher Stock Price Prediction 2029 | Thermo Fisher Stock Forecast 2029

YearMin PriceMax Price
2029$816.56$1,263.30

Thermo Fisher Stock Price Prediction 2030 | Thermo Fisher Stock Forecast 2030

YearMin PriceMax Price
2030$918.73$1,140.99

Thermo Fisher Stock Price Prediction 2035 | Thermo Fisher Stock Forecast 2035

YearMin PriceMax Price
2035$1,120.67$1,969.39

Thermo Fisher Stock Price Prediction 2040 | Thermo Fisher Stock Forecast 2040

YearMin PriceMax Price
2040$1,424.78$2,687.83

Thermo Fisher Stock Price Prediction 2045 | Thermo Fisher Stock Forecast 2045

YearMin PriceMax Price
2045$2,957.49$3,241.47

Thermo Fisher Stock Price Prediction 2050 | Thermo Fisher Stock Forecast 2050

YearMin PriceMax Price
2050$3,332.63$3,687.09

Thermo Fisher Stock Price Prediction 2060 | Thermo Fisher Stock Forecast 2060

will update soon

Read More – Cybin Stock Forecast 2025 2030 2040 2050 – Huge Psychedelic Wave

What are the PROs and CONs of investing in Thermo Fisher?

Here are the PROs and CONs of investing in Thermo Fisher –

PROs of investing in Thermo Fisher

CONs of investing in Thermo Fisher

Strong End-Market Growth – Thermo Fisher’s strong fundamentals, global economic activity, and pandemic response have led to impressive Q3 results, showcasing its resilience and growth potential.Foreign Currency Exposure – Thermo Fisher earns over 50% of its revenue from international markets, exposing it to currency fluctuations.
Diversified Product Portfolio – Thermo Fisher is a company that provides a wide range of solutions for different industries, unlike other companies that rely on just a few main products.Market Competition – Life sciences industry faces competition from established and emerging companies, impacting market share and pricing.
Positive Estimate Trends – Thermo Fisher’s estimated performance for 2021 has been positively revised, indicating confidence in their future.Regulatory Challenges – The company’s operations and profitability can be affected by changes in global economic conditions and regulatory policies.
Raised Guidance – The company increased its revenue (by 15%) and adjusted earnings per share ( suggesting 20% growth year-over-year) guidance for 2021.Management Turnover and Budget Cuts – The organization may face some challenges such as changes in management, reduced budgets, and staff burnout.
Strength in End Markets – Thermo Fisher is strong across various end markets, reporting over 20% growth in pharma and biotech due to exciting therapeutic areas like COVID-19 vaccines and therapies.Supply Chain Disruptions – Thermo Fisher can face supply chain disruptions due to various factors, impacting production, distribution, and overall business operations.
S&P 100 Component and Fortune 500 Ranking – Thermo Fisher Scientific is an S&P 100 component and a Fortune 500 company, with annual revenue exceeding $40 billion as of December 2023.Intellectual Property Risks – Thermo Fisher’s IP portfolio is crucial for its success. Legal challenges, patent disputes, or unauthorized use of its technology could harm its competitiveness and financial performance.
ESG Investment Potential – Thermo Fisher aims to create a healthier, cleaner, and safer world, which is in line with ESG investment criteria.
Steady Historical Performance – Thermo Fisher has delivered consistent execution of its strategy, rewarding investors with a remarkable 27,000% return in the last 40 years.

Who are the competitors of Thermo Fisher?

Here are the main competitors of Thermo Fisher –

  1. Abbott Laboratories
  2. Danaher
  3. Innobiochips
  4. ET Healthcare
  5. Illumina
  6. Boston Scientific

Videos Related to Thermo Fisher Stock Prediction

Conclusion

As we provided the details that above that, Thermo Fisher Scientific Inc. (TMO) is a global provider of life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services.

Despite market competition, revenue dependency, and regulatory challenges, the company’s commitment for expansion make it an attractive investment choice in the ever-evolving sensing and power sector.

We hope you will like the information given by us. And if you want more information related to stock prediction. You can read our article and stay with us so that you can know the prediction of more stocks in the future.

Also, do your due diligence and comment to us, whether you will invest in this stock or not. Till then Happy Investing.

Read More – EV Prosperity – MULN Stock Price Forecast 2025 2030 2040 2050 – Positive Fortunes Await!

Thermo Fisher Stock Prediction 2025 FAQs

Is Thermo Fisher stock a good buy?

According to the consensus rating, Thermo Fisher Scientific stock is considered a buy. This rating is based on a total of 57 ratings, including 51 buy ratings, 3 hold ratings, and 3 sell ratings.

What is the target price for Thermo Fisher?

We have already covered as –

YearMin PriceMax Price
2024$517.00$685.75
2025$657.20$904.77
2026$893.50$1,097.05
2027$1,077.37$1,224.49
2028$1,098.11$1,255.25
2029$816.56$1,263.30
2030$918.73$1,140.99
2035$1,120.67$1,969.39
2040$1,424.78$2,687.83
2045$2,957.49$3,241.47
2050$3,332.63$3,687.09

What is the current stock price of Thermo Fishers?

The current stock price of Thermo Fishers Ltd as of 27th Mar is $573.89.

What is the current market cap of Thermo Fishers?

The current market cap of Thermo Fishers Ltd as of 27th Mar is $218.71B.

Who owns Thermo Fishers? | Who invested in Thermo Fishers?

Thermo Fisher Scientific, a leading scientific research and development company, has a diverse ownership structure that consists of institutional investors like –

  • The Vanguard Group and BlackRock, who own significant stakes in the company. Moreover,
  • the company’s top-level executives, including CEO Michael H. Mahoney, also have notable ownership positions.

This blend of institutional investment and executive ownership reflects the company’s commitment to maintaining a balanced ownership structure that aligns with the interests of all stakeholders.

Should we invest in Thermo Fisher?

Investing in a high-quality company with a solid growth outlook at a reasonable price is always a wise decision.

Thermo Fisher Scientific, a renowned scientific instruments and laboratory equipment company, is expected to experience significant earnings growth of 37% in the coming years, indicating a highly optimistic future.

However, it is worth noting that much of this growth is due to the company’s expansion in previous years and only recently. Thermo Fisher’s sales and profits both experienced a decline in the first half of 2023, which is a significant concern for investors.

How has their stock performed over the past year?

Thermo Fisher Scientific’s stock performance over the past year –

  • Thermo Fisher Scientific’s stock price as of March 27, 2024, was $574.74 per share.
  • Over the last 12 months, TMO stock has had a total return of around 5.47%, while
  • the S&P 500 index has had a total return of approximately 34.43% during the same period.

Is Thermo Fisher profitable? | Is a Thermo Fisher company a profit-making company?

Thermo Fisher Scientific, a global leader in providing scientific solutions, has maintained a strong track record of profitability. As of December 31, 2023 –

  • Net Profit Margin – It’s worth noting that Thermo Fisher has a net profit margin of 13.99%, which indicates the company’s ability to generate profit after accounting for all expenses. In other words, this percentage reflects the portion of revenue that the company retains as income, which is quite impressive.
  • Gross Profit – In 2023, Thermo Fisher’s annual gross profit was $17.1 billion, which is 9.86% lower than the previous year. Nonetheless, Thermo Fisher remains a strong player in the industry.

What are the Benefits of investing in Thermo Fisher?

Thermo Fisher Scientific offers several compelling benefits –

  1. Strong End-Market Growth
  2. Diversified Product Portfolio
  3. Positive Estimate Trends
  4. Raised Guidance
  5. Strength in End Markets

Details are as follows –

Strong End-Market Growth – Thermo Fisher has been experiencing upward momentum due to the company’s solid fundamentals in the life sciences, coupled with a strong response to the pandemic and solid global economic activity. The company’s Q3 results were impressive, demonstrating its resilience and strong potential for growth.

Diversified Product Portfolio – Thermo Fisher distinguishes itself from other companies in the industry by offering a comprehensive suite of solutions that cater to a diverse range of industries. Unlike some companies that rely solely on a limited number of flagship products, Thermo Fisher’s product portfolio spans multiple sectors, providing a wide range of options to customers..

Positive Estimate Trends – Thermo Fisher has experienced a favorable pattern of estimate revisions for 2021, which signifies a strong belief in the company’s future performance. This suggests that the company is well-positioned to achieve its financial targets and that investors have confidence in its ability to deliver growth in the coming year.

Raised Guidance – The company has updated its financial projections for the year 2021, forecasting a 15% increase in reported growth compared to the previous year. Moreover, the adjusted earnings per share (EPS) guidance has been revised upwards, indicating a 20% growth rate year-over-year.

Strength in End Markets – Thermo Fisher is a powerhouse in several industries, including pharmaceuticals, biotechnology, diagnostics, and safety. Its recent financial report shows significant growth of over 20% in the pharma and biotech segment, particularly in the development of COVID-19 vaccines and therapies, which are considered exciting therapeutic areas.

What are the Challenges and Risks associated with Thermo Fisher?

updating…

Disclaimer

This article contains information that may be useful for those interested in the stock market. However, it is important to note that we do not provide recommendations to buy or sell any stocks. Investing in the stock market carries inherent risks, so it is crucial to conduct thorough research on any company before making any investment decisions.